The searchable archive below contains a list of Knight ADRC Tuesday Seminar presenters, the date of their presentation, institutional affiliation, and the title of their talk. The archive starts in 2000 with listings displayed in reverse chronological order (most recent first). Note that prior to 2020, some events may be missing or inaccurate due to last minute changes/cancellations.

Total Entries: 1254


 

DatePresenterAffiliationTitle
March 11, 2025E. James Petersson, PhD

University of Pennsylvania

Developing Therapeutic and Imaging Approaches for Alpha-Synuclein in Neurodegenerative Disease
March 4, 2025Miguel Minaya, PhD

WashU Medicine

Molecular Drivers of Tauopathies Identified Using Human Cell Models
February 25, 2025John C. Morris, MD, Justin Long, MD, PhD, Megan Lange, MSW, & Nicole Elmore, ANP-BS, CCRP

WashU Medicine

Knight Alzheimer Disease Research Center Clinical Core Update
February 18, 2025Virginia Lee, MBA, PhD

University of Pennsylvania

Transmission of Misfolded Proteins in Neurodegenerative Disorders: A Common Mechanism of Disease Progression
February 11, 2025Jennifer K. Phillips, MPA

WashU Medicine

Grief and Loss in Dementia Care
February 4, 2025Karen Joynt Maddox, MD, MPH

WashU Medicine

Health Policy Research in Alzheimer’s Disease and Related Dementias
January 28, 2025Fareeha Saadi, PhD

WashU Medicine

The Cell-Specific Insights into the Role of APOE4 in Cerebral Amyloid Angiopathy
January 21, 2025Michael Belloy, PhD

WashU Medicine

Towards Sex-Specific Genetic Precision Medicine in Alzheimer’s Disease
January 14, 2025Eva Klinman, MD, PhD

WashU Medicine

Cellular Hallmarks of Aging in Human Neurons
January 7, 2025Abhirami K. Iyer, PhD

WashU Medicine

Cell autonomous microglia defects in a stem cell model of frontotemporal dementia tau
December 17, 2024Guoqiao Wang, PhD

WashU Medicine

Engaging the Emerged Hot Topics in the Anti-amyloid Clinical Trials for Alzheimer Disease
December 10, 2024Marc Rudolph, PhD

WashU Medicine

Preliminary evaluation of plasma p-tau217 for detecting amyloid pathology in a diverse and heterogeneous community-based cohort
December 3, 2024Joy Snider, MD, Madeline Paczynski, MCMSc, PA-C, & David Carr, MD

WashU Medicine

Update on Amyloid Immunotherapy in the Clinic
November 26, 2024Ashish Sharma, PhD

WashU Medicine

An orexin receptor antagonist modulates microglia function to reduce amyloid pathology
November 19, 2024Sarah Hartz, MD, PhD

WashU Medicine

Assessing the clinical meaningfulness of slowing CDR-SB progression with disease-modifying therapies for Alzheimer disease
November 12, 2024Joyce (Joy) Balls-Berry, PhD, MPE & Andrea Denny, JD, MSSW

WashU Medicine

Building Cultural Intelligence in Medical Research: Understanding Bias and Microaggressions
November 5, 2024Gregory Van Stavern, MD

WashU Medicine

Retinal Imaging in Alzheimer’s Disease
October 29, 2024Nicolas Barthelemy, PhD

WashU Medicine

Recent advances in tau species analysis for AD diagnosis
October 22, 2024No Seminar

Norman R. Seay Lecture
October 15, 2024Mark A. Mintun, MD

Eli Lilly and Company

Perspectives on Diagnosis and Treatment of Alzheimer’s Disease
October 8, 2024Jony Kipnis, PhD

WashU Medicine

How brain borders affect brain physiology
October 1, 2024Brian Carpenter, PhD

WashU

What are People Thinking About Dementia? Recent Investigations into Attitudes & Information Seeking
September 24, 2024Joyce (Joy) Balls-Berry, PhD, MPE & Dotti McDowell, MA

WashU Medicine

A Recap of Understanding Systemic Racism
September 17, 2024Albert Lai, PhD, FACMI, FAMIA

WashU Medicine

Utilizing Electronic Health Records to Develop AI Methods for Alzheimer Disease
September 10, 2024David Carr, MD

WashU Medicine

Prescription Drugs, Driving and Older Adults: The Intersection of Happy and Healthy?